REBECCA BERGREN: Open Payments
NPI 1194075853 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,135 in 110 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $4,135
Food & beverage: $3,940Education: $195
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $753 |
| ABBVIE INC. | 14 | $452 |
| Janssen Biotech, Inc. | 6 | $336 |
| Incyte Corporation | 3 | $266 |
| Amgen Inc. | 4 | $255 |
| UCB, Inc. | 6 | $251 |
| Galderma Laboratories, L.P. | 16 | $250 |
| Novartis Pharmaceuticals Corporation | 5 | $220 |
| Organon LLC | 9 | $186 |
| Verrica Pharmaceuticals Inc. | 7 | $177 |
Products named: DUPIXENT, TREMFYA, Opzelura, Bimzelx, SKYRIZI, RINVOQ, VTAMA, YCANTH.
Industry payments across AZ — which companies pay providers there.
